Replicative Potentials of Various Fusion Products Between WI-38 and SV40 Transformed WI-38 Cells and Their Components
Overview
Authors
Affiliations
Hybrid cells derived from whole-cell fusions of replicating phase-II normal fibroblast cells (WI-38s) with SV40 transformed WI-38 fibroblast cells (CL-1s) demonstrated that the majority of the hybrid experimental cells still maintained a finite life-span. Approximately 2% demonstrated sustained and possibly indefinite replication. Experimental binucleate cells and subsequent hybrid synkaryons were also formed by fusing CL-1 karyoplasts into phase-II WI-38 replicating normal fibroblasts. In addition, viable cells were constructed from WI-38 fibroblast cytoplasts with CL-1 karyoplasts. Sustained replication was not observed in these crosses.
Therapy-induced senescence in cancer.
Ewald J, Desotelle J, Wilding G, Jarrard D J Natl Cancer Inst. 2010; 102(20):1536-46.
PMID: 20858887 PMC: 2957429. DOI: 10.1093/jnci/djq364.
Experimental elongation of telomeres extends the lifespan of immortal x normal cell hybrids.
Wright W, Brasiskyte D, Piatyszek M, Shay J EMBO J. 1996; 15(7):1734-41.
PMID: 8612598 PMC: 450086.
A gene involved in control of human cellular senescence on human chromosome 1q.
Hensler P, Annab L, Barrett J Mol Cell Biol. 1994; 14(4):2291-7.
PMID: 8139534 PMC: 358595. DOI: 10.1128/mcb.14.4.2291-2297.1994.
Ogata T, Oshimura M, Namba M, Fujii M, Oishi M, Ayusawa D Jpn J Cancer Res. 1995; 86(1):35-40.
PMID: 7737907 PMC: 5920584. DOI: 10.1111/j.1349-7006.1995.tb02985.x.
Human replicative senescence. A molecular study.
Hensler P Am J Pathol. 1995; 147(1):1-8.
PMID: 7604871 PMC: 1869881.